GoodRx appoints Romin Nabiey as Chief Accounting Officer

GoodRx Holdings, Inc.

Appointment effective April 20, 2022; Nabiey becomes principal accounting officer.
Nabiey succeeds CFO Karsten Voermann, who remains principal financial officer.
Nabiey has served at GoodRx since May 2017, most recently as SVP, Corporate Controller.
No new compensation has been determined for Nabiey in connection with the appointment.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Romin Nabiey

Chief Accounting Officer

GDRX · GoodRx Holdings, Inc.

Effective: 2022-04-20
Filed: April 25, 2022, 7:59 PM ET

On April 20, 2022, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”) appointed Romin Nabiey, Senior Vice President, Corporate Controller of the Company as the Company’s Chief Accounting Officer and designated Mr. Nabiey as the principal accounting officer of the Company, in each case effective immediately.

Role change

Karsten Voermann

Chief Financial Officer

GDRX · GoodRx Holdings, Inc.

Effective: 2022-04-20
Successor: Romin Nabiey
Filed: April 25, 2022, 7:59 PM ET

Mr. Nabiey succeeds Karsten Voermann, the Company’s Chief Financial Officer, in such role.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Romin Nabiey was appointed as Chief Accounting Officer at GoodRx Holdings, Inc..

Action: appointed
Role: Chief Accounting Officer

Exact text from the filing

On April 20, 2022, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”) appointed Romin Nabiey, Senior Vice President, Corporate Controller of the Company as the Company’s Chief Accounting Officer and designated Mr. Nabiey as the principal accounting officer of the Company, in each case effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Karsten Voermann changed role as Chief Financial Officer at GoodRx Holdings, Inc..

Action: succeeded
Role: Chief Financial Officer

Exact text from the filing

Mr. Nabiey succeeds Karsten Voermann, the Company’s Chief Financial Officer, in such role.

View on SEC.gov

GoodRx Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-117526

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.